A Multicenter, Phase 1, Open-label, Dose-Escalation and Expansion Study of TNB-383B, a Bispecific Antibody Targeting BCMA in Subjects with Relapsed or Refractory Multiple Myeloma

Project: Clinical Trial

Project Details

StatusNot started